The advantages for an H1 antihistamine of a low volume of distribution

Allergy: European Journal of Allergy and Clinical Immunology, Supplement

Volumn 55, Issue 60, 2000, Pages 17-21

  Tillement, J P ^a  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIVASTINE; ANTIHISTAMINIC AGENT; ASTEMIZOLE; AZELASTINE; CAREBASTINE; CETIRIZINE; EBASTINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; LEVOCABASTINE; LORATADINE; MEQUITAZINE; MIZOLASTINE; TERFENADINE;

CONTROLLED STUDY; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG HALF LIFE; DRUG PENETRATION; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG TRANSFORMATION; LIPOPHILICITY; PRIORITY JOURNAL; REVIEW; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; TISSUE DISTRIBUTION;

HISTAMINE H1 ANTAGONISTS; HUMANS; HYPERSENSITIVITY, IMMEDIATE; TISSUE DISTRIBUTION;

EID: 0034065429     PISSN: 01081675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. 1 antihistamines. Ann Allergy 1991;67:625-633.
2. 1-receptor antagonists: comparative tolerability and safety. Drug Saf 1994;10:350-380.
3. TILLEMENT JP, HOUIN G, ZINI R, et al. The binding of drugs to blood plasma macromolecules: recent advances and therapeutic significance. Adv Drug Res 1984;13:60-94.
4. HAAKSMA EEJ, LEURS R, TIMMERMAN H. Histamine receptors: subclasses and specific ligands. Pharmacol Ther 1990;47:73-104.
5. MCQUADE RD, RICHLAN K, DUFFY RA, CHIPKIN RE, BARNETT A. In vivo binding properties of non-sedating antihistamines to CNS histamine receptors. Drug Dev Res 1990;20:301-306.
6. CHESNE C, DEHOUCK MP, JOLLIET-RIANT P, et al. Drug transfer across the blood brain barrier: comparison of in vitro and in vivo models. Adv Exp Med Biol 1993;331:113-115.
7. 1-receptor antagonists) and cetirizine. Eur Ann Allergy Clin Immunol 1996;28:1-4.
8. 1-receptor antagonists. Ann Allergy 1987;59:20-24.
9. WOOD SG, JOHN BA, CHASSEAUD LF, YEH J, CHUNG M. The metabolism and pharmacokinetics of 14C-cetirizine in humans. Ann Allergy 1987;5:931-934.
10. SPENCER CM, FAULDS D, PELERS DH. Cetirizine: a reappraisal of its pharmacological properties and therapeutic use in selected allergic disorders. Drugs 1993;46:1055-1080.
11. MARKHAM A, WAGSTAFF AJ. Fexofenadine. Drugs 1998;55:269-274.
12. 1-antagonists. Clin Exp Allergy 1990;20:3-17.
13. 1-receptor antagonist. J Med Chem 1998;41:853-863.